title: Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
abstract: BACKGROUND
  Little is known about the risk factors for cutaneous human papillomavirus (HPV) infection.
  
  
  METHODS
  To investigate factors associated with cutaneous HPV seropositivity, we conducted a cross-sectional study of 411 patients undergoing routine skin cancer screening examinations. Serum antibodies were measured and evaluated for 36 cutaneous HPV types in the genera alpha, beta, gamma, mu, and nu. Associations of demographic and lifestyle factors with cutaneous HPV seropositivity were estimated using odds ratios and 95% confidence intervals calculated using logistic regression.
  
  
  RESULTS
  The seroprevalence of 1 cutaneous HPV type was 96% and 90% for men and women, respectively. Seroprevalence was highest for HPV types 4 (46%), 1 (37%), and 8 (31%) in men and for types 4 (47%), 63 (34%), and 1 (33%) in women. Independent associations of demographic and skin cancer risk factors with genus-specific HPV seropositivity differed by sex. For example, white skin, inability to tan, and lifetime residency in Florida were factors associated with genus-specific HPV seropositivity in men. Heavy smoking, sunscreen use, and green eye color were associated with genus-specific HPV seropositivity in women.
  
  
  CONCLUSIONS
  Seroreactivity to cutaneous HPV types was highly prevalent in our study population. Different risk factors were independently associated with genus-specific cutaneous HPV seropositivity in men and women.
authors.affiliation: Department of Cancer Epidemiology and Genetics, Moffitt Cancer Center, Tampa, Florida 33612, USA.
authors.forename: Michelle R
authors.initials: MR
authors.lastname: Iannacone
authors.forename: Kristina M
authors.initials: KM
authors.lastname: Michael
authors.forename: Anna R
authors.initials: AR
authors.lastname: Giuliano
authors.forename: Tim
authors.initials: T
authors.lastname: Waterboer
authors.forename: Michael
authors.initials: M
authors.lastname: Pawlita
authors.forename: Dana E
authors.initials: DE
authors.lastname: Rollison
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000914:Antibodies, Viral / Q000097:blood*; D003430:Cross-Sectional Studies; D005260:Female; D005431:Florida; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D027383:Papillomaviridae / Q000145:classification / Q000276:immunology*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000821:virology; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D017193:Skin Diseases, Viral / Q000453:epidemiology* / Q000821:virology; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral